Dr. Sarah K Sundet, D.O., MBA Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1400 Us Highway 61 Ste 240, Festus, MO 63028 Phone: 636-937-3337 Fax: 636-931-7671 |
News Archive
Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week's injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs). The president of the International Society for Stem Cell Research (ISSCR), Elaine Fuchs, Rockefeller University, U.S., stated that the setbacks for advancing biomedical research on stem cells and translating this knowledge into new and improved treatments for patients are already considerable, and escalate with each day the injunction continues.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
SpinalMotion, Inc., developer of the investigational Kineflex® lumbar and Kineflex®|C cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach. The data from the study will be used to support regulatory submissions for international commercialization.
Louisiana Gov. Bobby Jindal suggested delaying implementation of parts of the health law. Wisconsin Gov. Scott Walker recommends focusing on paring back Medicare and Social Security spending.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 6 days ago